Opioid Analgesics Market valuation is projected to total US$ 65.8 Bn in 2031, Says FMI Analyst

As per an exhaustive study by FMI, the Global Opioid Analgesics Market is anticipated to reach US$ 65.8 billion by 2031. In response to surging demand for post-surgery pain management and focus on novel drug formulations for analgesics, the market is estimated to expand at a CAGR of 5.4% over the forecast period 2021-2031, in comparison to the 4.2% CAGR registered from 2016 to 2020.

Opioid analgesics market is largely driven by the increasing prevalence of chronic disorders, neuropathic pain, and orthopedic diseases. Opioids are extensively used for anesthesia, cough suppression, cancer pain management, and treatment of several other conditions. In addition to this, the development of novel analgesics with fewer side effects is expected to spur sales by 1.7X through 2031.

A considerable rise in the number of surgical procedures has been reported in the last few years. According to the International Society of Aesthetic Plastic Surgery (ISAPS), around 11.3 million surgeries were reported across the world in 2019. As opioids are used as medications for managing and reducing pain post-surgeries, the surgical pain indication segment is anticipated to account for nearly 45.9% of the total sales by 2031.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-14043

As per FMI, Europe is projected to account for a considerable share in the global market, exhibiting sales growth at a CAGR of 5.4% between 2021 and 2031. The growth in the region is attributed to the increasing prevalence of chronic diseases and presence of favorable medical reimbursement policies in the U.K and Germany.

“Commercialization of non-abusive opioids and increasing availability of opioid analgesics through online distribution channels are expected to accelerate the sales of opioid analgesics,” says the FMI analyst.

Key Takeaways from Opioid Analgesics Market Study

  • The U.S. is anticipated to lead the market in North America, accounting for nearly 86% of the overall sales in 2021.
  • Sales of opioid analgesics in Germany are estimated to total US$ 2.2 billion, growing at a CAGR of 3.8% during the assessment period.
  • The market in India is forecast to account for 35.4% of the sales in South Asia, expanding at a CAGR of 5.7% between 2021 and 2031.
  • China is expected to emerge as the most lucrative market for opioid analgesics in East Asia, contributing around 54.2% of the sales revenue in the region by 2021 end.
  • Among drug class verticals, oxycodone is estimated to dominate the segment accounting for more than 19% of the global demand in 2021.

Key Drivers

  • Surging demand for facial and body aesthetics in response to the rising number of aesthetic surgical procedures such as breast implantation, eyelid surgeries, and abdominoplasty conducted worldwide will spur the sales across surgical pain segment.
  • Increasing adoption of opioid maintenance treatment (OMT) for treating opioid dependence (OD) across Germany, the U.K., the U.S., and others are anticipated to drive the market growth.

Key Restraints

  • Side effects associated with opioid analgesics such as drowsiness, nausea, constipation, clouded thinking, and psychological & physical addiction are hampering the market growth.
  • Stringent government regulation and guidelines regarding manufacturing, storage, marketing, and selling of opioid products are restraining the growth of opioid analgesics.

Discover more about the opioid analgesics analysis with figures and data tables, along with the table of contents. https://www.futuremarketinsights.com/ask-question/rep-gb-14043

Competitive Landscape

Leading manufacturers are emphasizing on launching new and revised products to enhance their product portfolios. Strategies such as product approvals, partnerships, agreements, merger, facility expansion, and collaborations are expected to assist market players strengthen their footprint and gain a competitive edge over other players. For instance,

  • In May 2020, Assertio Therapeutics, Inc., an American specialty pharmaceutical company, announced entering into merger agreement with a U.S.-based pharmaceutical company, Zyla Life Sciences. The merger will assist companies to expand their product portfolio of inflammation, neurology, and chronic pain medications.
  • In September 2018, Novartis, a Swiss multinational pharmaceutical corporation, announced signing an agreement for marketing, distribution, and sales, of well-known pain medicine brands such as Cataflam (diclofenac potassium) and Voltaren (diclofenac sodium) in Thailand, Malaysia and Philippines.
  • Pfizer Inc.
  • Abbott Laboratories
  • Janssen Pharmaceuticals, Inc. [Johnson & Johnson]
  • Novartis AG
  • Bayer AG
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche AG,
  • Boehringer Ingelheim International GmbH
  • Bausch Health Companies Inc.
  • Sanofi S.A.
  • Teva Pharmaceuticals
  • AbbVie Inc. (Allergan plc)
  • Purdue Pharmaceuticals L.P.
  • Sun Pharmaceutical Industries Ltd.

More Valuable Insights on Opioid Analgesics Market

FMI, in its new report, offers an unbiased analysis of the global opioid analgesics market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on in opioid analgesics market with detailed segmentation:

By Drug Class:

  • Morphine
  • Codeine
  • Fentanyl
  • Meperidine

By Indication:

  • Surgical Pain
  • Cancer Pain
  • Neuropathic Pain
  • Other

By Route of Administration:

  • Oral
  • Parenteral
  • Transdermal
  • Other

By End User:

  • Hospitals
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Get customized report as per your requirement – https://www.futuremarketinsights.com/customization-available/rep-gb-14043

Key Questions Covered in the Report

  • The report offers insight into opioid analgesics market demand outlook for the forecast period 2021-2031
  • The market study also highlights projected sales growth for opioid analgesics market between 2021 and 2031
  • Opioid analgesics market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • Opioid analgesics market share analysis, covering key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Nasal Antihistamines Market is expected to register a CAGR of 4.6% during the forecast period 2021-2031

As per a recent survey by FMI, the global Nasal Antihistamines Market is projected to total US$ 1.9 billion in 2021. Rising preference for alternative modes of drug administration other than injectable and oral is propelling the demand for the nasal drug delivery solutions. Driven by this, the market is expected to reach US$ 3.08 billion by the end of 2031.

A significant rise in prevalence of allergies has been witnessed across the world due to the increasing sensitization to allergens and intensifying air pollution. According to the Asthma and Allergy Foundation of America, allergies are the sixth leading cause of chronic illness in the U.S. The country reports over 50 million cases of allergies every year. Increasing demand for speedy relief from allergic reactions such as nose congestion, itchy and runny nose, and sneezing is creating immense sales opportunities for the market.

Several players in the market are focusing on launching novel products to capitalize on this opportunity. For instance, Glenmark Pharma announced launching a new nasal spray named Ryaltris in India in May 2021. In response to a slew of novel product launches, sales are expected to rise at a CAGR of 4.6% during the forecast period 2021-2031.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-13708

As per FMI, nasal sprays are the most preferred product available in the nasal antihistamines market, accounting for around 90% of global sales. Attributes such as fast relief, easy to carry, and cost-effectiveness are accelerating the demand for nasal sprays.

“Growing inclination towards the non-invasive treatments and increasing approvals by the Food and Drug Administration (FDA) for over-the-counter (OTC) sales of prescription-based nasal antihistamines are expected to favor the market growth in the coming years,” says the FMI analyst.

Key Takeaways from Nasal Antihistamines Market Study

  • The U.S. is expected to hold the largest revenue share in the North America market, accounting for 90.7% of sales in the region in 2021.
  • The U.K. is projected to emerge as a highly remunerative market, contributing more than 17.9% of sales in Europe in 2021.
  • The market in China is forecast to witness the fastest growth in East Asia, expanding at a CAGR of 6.5% over the assessment period.
  • Sales of nasal antihistamines in South Korea and Japan are anticipated to rise at 3.8% and 5.3% CAGR, respectively, by the end of the coming decade.
  • Based on distribution channel, retail pharmacies are estimated to account for over 40% of revenue share in the segment, projecting sales growth at a CAGR of 4.4% through 2031.

Key Drivers

  • Increasing healthcare expenditure, ease in product approvals, and rising funding for life science research, and new product launches are expected to accelerate the growth of the nasal antihistamine market.
  • Rising prevalence of respiratory diseases including asthma, allergic rhinitis, and others are fuelling the demand for low-cost generic medical products across China, India, Mexico, Brazil, and South Africa, which is propelling the demand for nasal antihistamines.

Key Restraints

  • Side effects associated with nasal antihistamines such as dizziness, dry mouth, and nose, headache, and others is hampering sales of nasal antihistamines.
  • Availability of alternatives such as oral antihistamines and others are hindering the growth of nasal antihistamines market.

Discover more about the nasal antihistamines analysis with figures and data tables, along with the table of contents – https://www.futuremarketinsights.com/ask-question/rep-gb-13708

Competitive Landscape

As per FMI, the global market is dominated by Bayer Healthcare, Novartis AG, Glenmark Pharmaceuticals, GlaxoSmithKline, Cipla, Merck & Co., Sun Pharmaceuticals, Viatris, Proctor & Gamble, Ascend Laboratories, Centaur Pharmaceuticals, J pharmaceuticals, Sato Pharmaceuticals, and Altair Pharmaceuticals.

Leading players are emphasizing on launching new products and receiving regulatory approvals to expand their product portfolios. Some of the manufacturers are aiming at engaging into strategic collaborations, acquisitions, agreement, and merger to increase their market share and expand their global presence. For instance,

  • In April 2020, Cipla, an Indian multinational pharmaceutical company, announced receiving final approval for its generic version of Proventil® High Functioning Autism (HFA) Inhalation Aerosol, from the U.S. FDA. The product approval will assist the company to strengthen their presence in the U.S. pharmaceutical market.
  • In December 2020, GlaxoSmithKline, a leading pharmaceutical company in India, announced launching a saline wash natural nasal spray, Otrivin Breathe clean. It offers symptomatic relief from allergic rhinitis with moisturizing benefit as it has natural glycerin in it.

Some of the key players operating in the market profiled by FMI are:

  • Bayer Healthcare LLC
  • Novartis AG
  • Glenmark Pharmaceuticals
  • GlaxoSmithKline
  • Sun Pharmaceuticals
  • Cipla
  • Merck & Co.
  • Viatris (Meda Pharmaceuticals)
  • Proctor & Gamble
  • Ascend Laboratories LLC (Alkem Laboratories)
  • Centaur Pharmaceuticals
  • J Pharmaceuticals
  • Alitair Pharmaceuticals
  • Sato Pharmaceuticals

More Valuable Insights on Nasal Antihistamines Market

FMI, in its new report, offers an unbiased analysis of the global nasal antihistamines market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on in nasal antihistamines market with detailed segmentation:

By Product:

  • Nasal Spray
  • Nasal Drops

By Age Group:

  • Adult
  • Pediatric

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

We Offer tailor-made Solutions to fit Your Requirements, Request Customization – https://www.futuremarketinsights.com/customization-available/rep-gb-13708 

 Key Questions Covered in the Report

  • The report offers insight into nasal antihistamines market demand outlook for the forecast period 2021-2031
  • The market study also highlights projected sales growth for nasal antihistamines market between 2021 and 2031
  • Nasal antihistamines market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • Nasal antihistamines market share analysis, covering key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Cold Laser Therapy Market is poised to expand at a CAGR of 4.4% between 2021 and 2031

Demand for Cold Laser Therapy Market is projected to witness steady growth at a 4.4% CAGR during the forecast period (2021-2031). Sales in the Cold Laser Therapy Market are expected to top US$ 165.4 Mn by 2031-end.

Surging cosmetic & non-invasive surgeries and rise in number of aesthetic laser techniques are major factors boosting the market. Growing trend of having flawless skin, coupled with increasing influence of social media will spur the demand for cosmetic procedures. Thereby, increasing the adoption of cold laser therapy.

As prevalence of musculoskeletal disorders and number of dental surgeries are increasing, demand for cold laser therapy is expected to increase. Application of cold laser therapy in pain management and dermatology will spur the sales during the forecast period.

Further, increasing awareness regarding various benefits of cold laser therapy is improving the adoption of cold laser or low-level laser therapy devices. As per FMI, s ales in the cold laser therapy market is expected to top US$ 107.6 Mn by 2021.

Request a report sample to gain compressive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-3639

Additionally, key players are increasing research and development expenditure of biotechnology companies is expected to create incremental growth opportunities for market players.

“Growing demand for aesthetic cosmetic procedures and penetration of social media platforms have increased the demand for non-invasive procedures and low-level laser devices. This is expected to increase the sales of cold laser therapy market,” says the FMI analyst.

Key Takeaways from Cold Laser Therapy Market Survey

  • In terms of product, continuous laser devices will account for the largest market share of 57% market share in 2021
  • Single wavelength cold laser therapy is expected to be the most preferred technology among end-users
  • Application of cold laser therapy in dermatology will account for more than 35% of total market share in 2021
  • Specialty clinics are expected to be the primary end-users owing to the growing patient pool for cosmetic treatment and pain management
  • The U.S. cold laser therapy market will account for over 92% of sales in North America
  • Germany is expected to witness incremental growth opportunities for cold laser therapy market owing to the high presence of numerous leading players
  • China and India will register high growth across East and South Asia market, exhibiting 6% CAGR and 6.1% CAGR, respectively

Key Drivers

  • Increasing application of cold laser therapy in orthopedic injuries will push the sales over the forecast period
  • Growing adoption of low-level laser devices among rising number of dental practitioners is expected to fuel the growth in the market

Key Restraints

  • High deployment cost and lack of skilled professionals equipped with technical expertise is likely to hamper the sales.

Talk to Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3639 

Competitive Landscape

Key players in cold laser therapy market are focusing on strategic collaborations, coupled with product launches in order to retain their dominance in the industry. Some of the manufacturers are also expand their product portfolio through mergers and partnerships with other key players.

For instance,

  • In 2020, Multi Radiance Medical announced the start of non-pharmaceutical clinical trial using photobiomodulation and cold laser therapy to treat intubated COVID-19 patients to improve critical care.
  • Apira Science Inc. received approval from the KFDA (Korea Food and Drug Administration), the FDA Thailand, and the Singapore Health Sciences Authority (HSA), in 2018, to bring iGrow’s patented low-level light therapy (LLLT) technology to these markets.

Leading players operating in the cold laser therapy market profiled by FMI include:

  • Apira Science Inc.
  • BioLight Technologies LLC
  • B-Cure laser Australia
  • Erchonia Corporation
  • Theralase Inc.,
  • THOR Photomedicine Ltd
  • DJO Global, Inc.
  • BTL
  • Spectro Analytic Irradia AB
  • Photomedex
  • Others

More Insights on the Global Cold Laser Therapy Market

Future Market Insights, in its new offering, presents unbiased analysis on the global cold laser therapy market. The study divulges into compelling insights of the cold laser therapy market for the historic period (2016-2020) and for the forecast year (2021-2031) as well. In order to gain better perspective on prominent growth drivers and trends, the market is segmented on the basis of:

Product:

  • Continuous Laser Devices
  • Pulse Laser Devices
  • Combination Laser Devices

Application:

  • Pain Management
  • Arthritis
  • Wound Healing
  • Nerve Regeneration
  • Dermatology
  • Musculoskeletal
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

We Offer tailor-made Solutions to fit Your Requirements, Request Customization – https://www.futuremarketinsights.com/customization-available/rep-gb-3639

Key Questions Covered in the Cold Laser Therapy Market

  • The report offers insight into cold laser therapy demand outlook for 2021-2031
  • The market study also highlights projected sales growth for cold laser therapy market between 2021 and 2031
  • Cold laser therapy market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • Cold laser therapy market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Date Syrup Market Is Expected To Surpass US$ 630.0 Mn By 2031, Exhibiting Growth At Healthy CAGR Of 6.4% For 2021-31

Future Market Insights’ (FMI’s) latest report offers comprehensive insights into the global date syrup market. The report forecasts the market to grow by 6.4% CAGR between 2021 and 2031.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14103

Consumer preference for clean label products and ingredients derived from natural sources for their food items will steer growth in the market. The same trend is driving sales of date syrup in nutraceutical and cosmetics industry.

Growing product knowledge has resulted in more awareness in consumers than ever before. Today, consumers are just not satisfied by choosing any food just because its label says “high quality”, but they intend to know its constituents and processing.

Looking at this trend, leading manufacturers in food, skincare, and other industries are providing products that are free from or contains negligible amounts of preservatives, artificial sweeteners and flavors.

Moreover, the national and international food safety regulations and standard operating procedures’ compliance also have compelled many food producers to eliminate the use of such additives while processing.

For instance, Arat Company Pjs, ensures strict compliance to BRC Grade AA, IFS, ISO 22000 Food Safety, Kosher, ISO 9001:2015, HACCP, ISIRI and Halal and includes nothing but dates and water for processing and producing its high quality dates syrup.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-14103

Key Takeaways from the Date Syrup Market Study:

  • Date syrup market is expected to total US$ 630 Mn by 2031.
  • The Middle East and Africa (MEA) will emerge as the leading market, accounting for the lion’s share of date syrup sales. FMI has pegged the demand in MEA to grow by 5% CAGR.
  • In North America, sales of date syrup will accelerate on account of surging demand from the U.S.
  • Within Europe, Germany, France and the U.K. will spearhead sales of date syrup.
  • Despite China’s dominance in East Asia, sales of date syrup will increase at a higher rate in Japan and South Korea.

 “Companies operating in the date syrup market are offering the products in different quality grades. This has enabled the manufacturers to attract new customers from the foodservice and food & beverages industry. Depending upon a customer’s need, the product can be provided.” said a lead analyst at FMI.

Need for Stable Shelf-life Products Driving the Demand for Date Syrup

Work-centric lifestyles of dominating population has caused a major shift in demand for the type and properties of food products. People today are opting for food items that have extended seasonality, easy application, and multi-purpose for the sole reason of convenience, which these food products offer to the evolving consumers.

This has compelled several leading manufacturers to subsidize research and development to uncover more natural ways to keep food shelf-stable for an extended period of time.

Date syrup is no exception to this. The product itself is insured of seasonality as soon as it is produced. Even the syrup manufacturers with their innovation potentials, have developed syrups that do not even require the application of refrigeration to ensure slow degradation.

For instance, Ratinkhosh Co., provides a minimally processed dates syrup, which comes with a shelf-life of 2 years without the use of any type of preservatives or artificial ingredients.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-14103

Who is Winning?

Some of the leading companies offering date syrup are Al Foah, Malabar Food Products, Just Dates Syrup, Ario Co, Sun Seas Business Group, BIONA, Parsunday Symbol Co., BOMBUS, Rapunzel Naturkost, D’VASH Organics, Ratinkhosh Co, EZEEBEE OVERSEAS PVT LTD, Lion Dates Impex Pvt. Ltd., Ambrosia Delicatessen, ARAT COMPANY PJS, Minoo Industrial Group, Emirates Dates, Date Lady, and Others.

Foley Catheter Market is expected to surge past valuation of US$ 2.2 Billion by the end of 2030

The prevalence of urological diseases – such as urinary retention, benign prostate hyperplasia (BPH), bladder obstruction, urinary incontinence, and prostate cancer – has witnessed a significant uptick in the recent past. According to the statistics of the Centers for Disease Control and Prevention (CDC), nearly 15-25% of hospitalized patients receive a urinary catheter annually. As the number of hospital admissions continues to rise year-on-year, there is a persistent need for foley catheters in hospitals, which are projected to remain a crucial end-use segment.

Likewise, the growing burden of urinary retention, a chronic condition in which individuals cannot voluntarily urinate, is propelling demand for foley catheters to facilitate easy drainage of urine. As per the estimates of the American Academy of Family Physicians (AAFP), approximately 4.5 to 6.8 per 1,000 men in the US suffer from urinary retention. As the incidence of disorders continues to grow across the world, the demand for foley catheters is poised to remain high for the years to come.

Along similar lines, the high prevalence of urinary incontinence, a condition that causes the urine to leak involuntarily, is projected to bestow remunerative opportunities to players in the foley catheters market. The severity of urinary incontinence rises with age, with men above 70 being the most affected. The expanding base of the geriatric population will continue to necessitate the usage of foley catheters.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-7769

Having analyzed and scrutinized all the aforementioned facets in its new market study, Future Market Insights (FMI) projects that the global foley catheters market will grow in value at a CAGR of nearly 5% between 2020 and 2030. Some of the key takeaways from the report include:

  • The global foley catheters market is expected to surge past valuation of US$ 2.2 Bn by the end of 2030.
  • By product type, 2-way foley catheters are poised to remain the most sought-out variants, owing to their wide availability and simple installation, and will hold more than half of the overall market value.
  • Among materials, latex-based foley catheters are expected to gain an edge over their counterpart, silicon-based foley catheters, backed by their ability to reduce urethral irritation.
  • Based on indication, urinary incontinence is expected to remain the largest segment, on the back of high incidence among geriatric population.
  • North America will remain at the forefront of the regional landscape ascribed to high expenditure on medical aids coupled with new product approvals.
  • Asia Pacific and Europe will continue to bestow remunerative opportunities to market players.

“With catheter-acquired infections being a major challenge to the adoption of foley catheters, manufacturers are focusing on developing products with materials and coatings that aid in reducing accumulation of bacteria, thus restraining the possibility of catheter-acquired infections among patients” remarks FMI analyst.

COVID-19 Impact on Foley Catheters Market

COVID-19 is expected to create slight fluctuations in the growth trajectory of the foley catheters market. There has been a notable shift in priorities of healthcare institutions, with treatment for COVID-19 patients being the utmost priority across the world. Hospitals in severely affected nations such as the US and India have deprioritized non-essential hospitalizations, leading to a downfall in the demand for foley catheters. With urology not being the most concerning healthcare issue currently, the sales of numerous urology care devices, including foley catheters are likely to witness a decline across hospitals. However, the demand for foley catheters in long-term care facilities is poised to remain unhinged through the pandemic, and will continue to drive the sales of these devices.

Major players in the market are focusing on developing advanced catheters that reduce the likelihood of the patient developing catheter-associated infections. To achieve the same, they are using novel materials and coatings, and are seeking approvals to commercialize their devices. On these lines,

  • C.R Bard is using silver-ion and antimicrobial coatings in the production of foley catheters to eliminate the risk of catheter-associated infections when used for long periods.
  • B. Braun Melsungen AG continues to develop its catheter product line named Actreen® catheters, designed specifically for urinary retention, and are coated with lubricants to make it comfortable and hygienic to use.
  • In 2019, Safe Medical Design Inc., procured FDA approval to commercialize its new catheter designed to reduce to urethral trauma.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-7769

FMI’s report includes profiles of some of the most prominent names in the market including:

  • Teleflex Incorporated
  • Cardinal Health
  • C.R Bard
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Medtronic plc
  • Flume
  • ConvaTec Group
  • VOTG Medical
  • Sterimed Group
  • Ribbel International Limited
  • Angiplast Private Limited
  • Mais India Medical Devices Private Limited
  • JK Medirise.

Key Segments

Type:

  • 2 Way
  • 3 Way
  • 4 Way

Material:

Latex Foley Catheter

  • Hydrogel-Coated Latex Foley Catheters
  • Silicon-Coated Latex Foley Catheter
  • Silver-Coated Latex Foley Catheters
  • “PTFE (polytetrafluoroethylene) (teflon)
  • Coated Latex Foley Catheters

Silicon Foley Catheter

  • Hydrogel-Coated Silicone Foley Catheters
  • Pure Silicone Foley Catheters
  • Silver Coated Silicon Foley Catheters
  • Others

Indication:

  •  Urinary Incontinence
  •  Urethral Stricture
  •  Chronic Obstruction
  •  Neurogenic Bladder
  •  Enlarged Prostate Gland/BPH
  •  Prostate Cancer
  •  Others

End-user:

  • Hospitals
  • Long Term Care Facilities
  • Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-7769

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Advance Wound Care Market 2021 Industry Research, Segmentation, Key Players Analysis and Forecast to 2031

According to a recent study by Future Market Insights (FMI), the advance wound care market is expected to grow from US$ 10.7 Bn in 2021 to US$ 15.4 Bn by 2031. The market is poised to expand at a CAGR of 3.7% over the forecast period (2021-2031).

Rising prevalence of chronic wounds has created a significant socioeconomic impact. The treatment of chronic wounds requires advance wound care therapies and generally takes long time to heal. The prevalence of diabetic ulcers is rising by 9% annually.

Growing patient pool for diabetic foot ulcer is increasing as compared to the available advance wound care management technologies. Currently, there are more than 4.5 million pressure ulcer patients in the world that require treatment.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13947

More than 9.7 million venous ulcer patients and roughly 10.0 million diabetic ulcer patients require treatment across the world. Annually, over 5 million chronic leg ulcer cases occur in Brazil, while approximately 2.7 million chronic leg ulcer cases occur in Mexico.

Hence, with rising need for advance wound care products for the treatment of various chronic disorders, adoption within hospitals and ambulatory surgical centers is expected to increase. Thereby, bolstering market growth.

Number of pressure and venous ulcer patients has grown from approx. 7% in developed countries, such as the U.S., Germany, and the U.K., which is further expected to drive the growth of the market for advance wound care products.

Focus on collaboration with surgeons for better wound management, improvement and streamlining of regulatory processes and inter and intra-departmental collaboration between surgeons and their support staff for wound management plays a key role in ensuring better wound management and promotes the growth of the advance wound care market.

Key Takeaways from Advance Wound Care Market Study

  • By product, wound cleansers segment is likely to grow at a CAGR of 4.6% in the projected period, occupying a market share around 30% by 2031.
  • By distribution channel, the institutional sales are projected to capture over 70.2% market share of the global advance wound care market by 2031.
  • North America is the largest revenue-generating region for the global advance wound care market, with the U.S. accounting for nearly 90% market share in 2031.
  • China is expected to spearhead the growth in East Asia advance wound care market and is poised to expand at an impressive pace of 7.0% CAGR over the decade.
  • East Asia is the third most lucrative market, acquiring a market share of more than 15%, for the advance wound care market.

“Increasing prevalence of chronic wounds and growing awareness towards adoption of medical treatment across the globe will propel the market growth over the next ten years,” says the FMI Analyst

Who is Winning?

Some of the leading manufacturers of advance wound care market are focusing on product launch and expansion strategies for global expansion objectives, thereby, enhancing their market presence.

  • In June 2021, Mölnlycke started a new surgical glove factory in Malaysia to increase its production capacity. The new surgical glove reduces the risk of allergic contact dermatitis for surgeons and nurses.
  • In Feb 2021, Coloplast A/S launched Biatain® Fiber portfolio to contribute positively to the market’s growth in France and Germany. Technology is an absorbent gelling fiber, for highly exuding wounds, sloughy wounds and cavity wounds including undermining and facilitates autolytic debridement and desloughing which promotes the wound healing process.
  • In June 2021, Ethicon Inc. launched the ENSEAL X1 Curved Jaw Tissue Sealer, a new advance after-surgery wound healer. It’s a   Bipolar energy device increases procedural efficiency and provides stronger sealing of wound.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-13947

The key market players covered by FMI include B. Braun Melsungen AG, Mölnlycke Health Care, ConvaTec Group plc, Coloplast A/S, Johnson and Johnson, Medline Industries Inc., 3M, QIAGEN N.V, Essity AB (BSN Medical), Smith and Nephew plc, BOENMED, Hakuzo Medical Asia Co. Ltd.

Key Questions Answered in the Report

How much is the advance wound care products market worth?

What are the key trends in advanced wound care?

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/13947

Contact Us:                                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Airless Pumps Market To Increase At 5.5% CAGR Between 2021 And 2031

Globally the sales of airless pump are estimated to grow 1.8 times over the upcoming decade, as heavy demand for contamination-free packaging solutions surges across the globe. As per Future Market Insights (FMI), the global airless pump market is anticipated to exhibit growth at 5.5% CAGR between 2021 and 2031.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13418

Present day consumers are more aware about their personal care and cosmetic products. Their knowledge is no longer limited to ingredients list of personal care or cosmetic products, but covers benefits that some packaging can offer over others.

Consumers are even willing to pay more for packaging that reduces contamination of formula and ensures minimum wastage. Airless pumps are used for packaging body lotions, make ups, perfumes & deodorants, and several others products. Consumers, especially millennials prefer airless pumps for as they maintain the product integrity for a longer duration.

Airless packaging solutions, including airless pumps, are registering strong sales as they are available in a wide range of decorative bottles and containers with a sophisticated luxury feel. Demand for such highly customizable yet technology-oriented airless pumps is at all-time high, which is estimated to reinforce the market growth to a significant extent.

In addition to this, the global e-commerce industry is expanding with its improvised business models and inventory and shipment operations.  The increasing shopping of an extensive range of personal care, beauty and cosmetic product via online platforms is fuelling sales of airless pump to a great extent.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-13418

Key Takeaways from Airless Pump Market

  • Handheld airless pump are gaining traction in the market. They are expected to accounts for almost 70% market share in 2021.
  • As per FMI, the demand for airless pumps made up of plastic is estimated to grow at 5.1% CAGR between 2021 and 2031.
  • Application in body lotion packaging is anticipated to offer a total incremental opportunity of US$ 57.1 Mn over the upcoming decade.
  • Demand in Asia-Pacific is expected to grow at a 6.8% CAGR over the forecasted period.
  • The U.S. in North America and Germany in Europe will spearhead the sales of airless pumps.

“Impressive growth in demand of cosmetics & beauty care products is driving the sales of airless pump. The market also will gain from the expansion of global personal care brands,” says FMI analyst.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-13418

Manufacturers Eyeing Luxury and Premium Packaging for Beauty Personal Care Industry

Manufacturers operating in the global cosmetic and personal packaging market are offering highly customized and luxury packaging solutions. Premium packaging adds aesthetics along with sophistication of functionality.

Airless pumps are available in a variety of glossy bottles and jars. As compared to flexible cosmetic packaging solutions, airless pumps can be converted into versatile end-products with customizable add-on features. Due to the intensifying competition in the cosmetic and personal packaging market, airless pump manufacturers are likely to focus on offering innovative packaging solutions.

Active Humidifier Devices Market 2021 Key Players, End User, Demand and Consumption by 2031

According to a recent study by Future Market Insights (FMI), the active humidifier devices market is expected to witness sluggish growth during the forecast period. The market is slated to grow from US$ 1.23 Bn in 2020 to over US$ 1.0 Bn by 2031. This reflects a cumulative CAGR of around -2.2% over the forecast period (2021-2031).

The current market scenario depicts a competitive landscape and is anticipated to witness significant growth during the forecast period. Growing respiratory disorders across the globe due to the outbreak of COVID -19 virus, created a sharp rise in demand for ventilators across the globe.

As humidifiers are used to provide humidified air to patients who require respiratory assistance, the demand for these devices increased during the pandemic, especially across India, China, and the U.S. Also, the outbreak of infectious diseases affecting respiratory systems, acceptance of high flow nasal cannula for oxygen therapy is anticipated to drive the sales of active humidifier devices.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13929

Growing geriatric population with respiratory disorders has improved the adoption of non-invasive ventilators. However, due to increasing severe cases of COVID-19 across the globe, need for invasive heated/electronic humidifier devices have surged the sales worldwide.

As per Future Market Insights, invasive ventilation segment is accounted for over 46.8% during 2021 and is expected to witness steady growth during the forecast period. With high prevalence of air borne diseases and respiratory diseases, demand for heated/electronic active humidifier devices is expected to witness substantial growth over the forecast period.

The heated/electronic active humidifier devices will hold over 56.5% of global market share through 2031, estimated by Future Market Insights. In past, the development and launch of technologically advanced new solutions to meet patients’ expanding respiratory needs is expected to bolster active humidifier devices market growth.

active humidifier devices market characteristics and attributes with regional relevance 2021

Key Takeaways from Active Humidifier Devices Market Study

  • By product, heated/electronic humidifier devices accounted for the largest share of 56% in 2021 and are expected to continue to grow during the forecast period.
  • By age group, adult segment is expected to account for the largest share of 88% in 2021 of global active humidifier devices.
  • In terms of application, invasive ventilation is expected to account for the largest share of 47% during in 2021.
  • By end user, hospitals accounted for the largest share of 65% in 2021 and are expected to grow at the steady pace during the forecast period.
  • North America held the largest share of 28.7% in 2021 of the global active humidifier devices market. Emergence of new infectious diseases affecting respiratory systems, presence of leading manufacturers, and growing market consolidation activities has fueled the growth of the active humidifier devices market in North America.

“Surging demand amid COVID-19 outbreak and acceptance of high flow nasal cannula therapy will drive the humidifier devices market over the next ten years,” says the FMI Analyst

Who is winning?

Some of the leading manufacturers of active humidifier devices market are focusing on product launches and expansion strategies such as collaboration and mergers with other key players to expand their customer base, thereby, improving their market presence.

  • In July 2021, Breas Medical and Dräger entered into an agreement, together, wherein, they will provide extended support for providing ventilation solutions into the U.S. long-term care facilities.
  • In July 2021, Koninklijke Philips N.V.  announced the acquisition of Capsule Technologies, Inc. to expand its leadership in patient care management.
  • In April 2020, Vapotherm expanded its production capacity for high-flow nasal cannula systems, in response to the growing demand for high-flow nasal cannula systems, which are used for treating COVID -19 respiratory distress.
  • In May 2020, Inspired Medical’s Inspired O2FLO high flow respiratory humidifier has received Emergency Use Authorization (EUA) by U.S. FDA. This device will be available for emergency use in healthcare settings to treat patients with hypoxemia and other-acute respiratory symptoms. Additionally, O2FLO also meets homecare safety requirements which makes them safe for home use and also is IEC60601-11 compliant.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-13929

The key market players profiled by FMI include Teleflex Incorporated, Koninklijke Philips N.V., Fisher & Paykel, ResMed, Vapotherm Inc., Vincent Medical Ltd (Inspired Medical), Sumed (Salter Labs), WLAMed GmbH, Penlon Ltd., DEAS S.R.L., Beijing Aeonmed Co., Ltd., Flexicare (Group) Limited, GalMed Corporation, and Vadi Medical Technologies.

What is the Impact of the COVID-19 on the Market?

Adevnt of COVID-19 is anticipated to have a positive impact on the growth of the active humidification market, specifically for heated/electronic humidification devices. In the FQ-20, cases of coronavirus witnessed sudden spike, especially in India, which provided major boost to the active humidifier devices demand.

Also, even with the commencement of vaccination drive across the globe, cases are still increasing in some regions across the globe, which is keeping the market demand steady. Now, with growing awareness among the consumers for their health, as a precautionary measure consumers are increasing the adoption of these devices, especially for the patients in home-care settings.

Active Humidifier Devices by Category

Product Type:

  • Heated/electronic Humidifiers
  • Bubble Humidifiers
  • Accessories

Age Group:  

  • Adult
  • Paediatric
  • Neonates

Application:

  • Invasive Ventilation
  • Non-invasive Ventilation
    • nCPAP (Nasal Continuous Positive Airway Pressure)
    • Bubble CPAP (Bubble Continuous Positive Airway Pressure)
  • High Flow Oxygen Therapy

End User:

  • Hospitals
    • Less than 100 Beds
    • 100-300 Beds
    • 300-500 Beds
    • 500 Beds and More
  • Ambulatory Surgical Centers
  • Sleep Centres

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Key Questions Answered in the Report

How much is the active humidifier devices market currently worth?

What are the key market statistics in China?

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/13929

Contact Us:                                                                            

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Biodegradable Baby Diapers Market Is Expected To Surge At 7.5% CAGR During The Forecast Period, From 2021 To 2031

Increasing adoption of baby diapers and growing awareness towards environmental impact of disposable of baby diapers have surged the sales of biodegradable baby diapers. As per Future Market Insights (FMI), the demand for biodegradable baby diapers is expected to surge at 7.5% CAGR during the forecast period, from 2021 to 2031.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-8091

Parents today have increasingly turned conscious not only for their babies but also in terms of environment. As per the recent statistics of 2021, diapers are third largest consumer product that end up in landfills. Accumulating diapers waste in an average household with kids and infants that wear diapers has become a serious concern.

As biodegradable diapers can be easily decomposed, key players are increasing the production to curb the environmental pollution and generate revenues. As parents are increasingly becoming aware regarding the pollution, they are switching to eco-friendly and chemical free products.

Along with the environmental impact, the market players are underpinning safety offered by promoting biodegradable baby diapers as dermatologically tested. This also has encouraged greater innovation in the market.

For instance, Bamboo Nature is one such brand that incorporates a color-changing moisture indicator, a feature that indicates when change is needed. Such efforts on the part of players are likely to scale up the adoption of biodegradable baby diapers in the coming years.

Increasing penetration of social media is playing a vital role in influencing the perception of new parents. Efforts undertaken by several mothers and baby health experts on social media has played a significant role in impacting consumer’s buying decision in the past few years.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-8091

Besides this, the campaigns and initiatives undertaken by players to promote the impact of diapers on environment is likely to further reshape consumer preferences. Huggies is one such brands that has taken an active initiative in spreading awareness regarding the impact of diapers on environment and thus promoting biodegradable options.

Such brand initiatives are further expected to play a key role in spreading awareness regarding biodegradable options especially in the developing countries where awareness levels are low.

Key Takeaways from the Biodegradable Baby Diapers Market Study

  • In terms of product type, pant style diapers are expected to reflect a strong CAGR growth as compared to tape style diapers. As per FMI, pant style diapers are expected to grow at a CAGR of 8.3% during the forecast period.
  • In terms of pricing premium biodegradable baby diapers are expected to register a significant CAGR as the new parents have turned increasingly conscious and least compromise on essential baby products.
  • The U.S. holds a market share of 79.4% in North America in 2021 owing to the rapid upsurge in the awareness level regarding the impact of diapers on environment.
  • The U.K. is expected to emerge as a key market in Europe, reflecting growth high growth  owing to higher spending on premium products in the country.

“Key players are increasingly focusing on improving their digital marketing skills as their sales are widely generated through online retailers and social media. Hence, they are adopting strategies such as social media campaigns, digital media marketing, and promotional videos to reach larger audience and gain competitive edge in the industry.” says an FMI analyst.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-8091

Who is Winning?

Leading manufacturers of biodegradable baby diapers are focused on extensive promotional strategies, advertisements, and new product developments which is expected to drive the demand for biodegradable baby diapers across the globe.

Major players present in the biodegradable baby diaper market are Seventh Generation, Inc., Naty AB, The Honest Company, Abena A/S, KAS Direct, LLC, Broody Chick Company, Hansen Kids LLC, Drylock Technologies NV, Hengan International Group Company Limited, The Hain Celestial Group, Inc., Kimberly-Clark Corporation, Kao Corporation, Bumkins Company, The Procter & Gamble Company, Ontex Group and Unicharm Corporation among others.

U.S. Automotive and Aircraft Interior Genuine Leather After Market is projected reach a valuation of nearly US$ 7.8 Billion and Forecast 2021-2031

The U.S. automotive and aircraft leather aftermarket is projected to reach a valuation of US$ 7.8 Bn in 2021. Rising demand for high-quality, lightweight, and durable leather for automotive and aircraft interiors is expected to push sales at 3.6% CAGR, with the market valuation reaching US$ 11.1 Bn in 2031.

Automotive and aircraft interior genuine leather is designed to provide comfort and to improve the visual appeal of the interiors. It also leaves the vehicle with a remarkable appearance and feel. It is used widely in midrange and premium passenger vehicles and in business class aircraft.

The interior of a vehicle and aircraft that adds to the aesthetic appeal, is also a major factor that influences consumer buying decision. Longer operational life and extended warranties are some factors aiding the growth of the market.

Leather manufacturers are providing customization to meet the changing consumer requirements. This provides the end-user with a large selection of leather types to pick from, ranging from basic to advance.

As per FMI’s analysis, the automotive in end-use segment is anticipated to dominate the U.S. automotive and aircraft interior genuine leather aftermarket. Growth can be attributed to strong presence of key automotive and aviation players in the U.S., along with rapid adoption of new technologies to manufacture more efficient and durable leather. These trends will continue augmenting growth of the market over the assessment period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-14237

Key Takeaways:

  • By end-use, the automotive segment is expected to account for more than half of total market share in 2021.
  • In terms of applications, sales in the passenger cars segment are projected grow at a 3.6% CAGR through 2031.

“The introduction of latest technologies in automotive seating such as climate-controlled seats in electric and hybrid vehicles is expected to boost demand. In addition to this, growing preference for lightweight vehicles is expected to bode well for the market in the forthcoming years,” says an FMI analyst.

Competitive Landscape

Leading players operating in the U.S. automotive and aircraft interior genuine leather aftermarket include Lear Corporation., WOLLSDORF LEDER SCHMIDT & Co. Ges.m.b.H, Bader GmbH & Co. KG., Leather Resource Of America Inc., Katzkin Leather, Inc., Hydes Leather, Carroll Leather., Alea Leather Specialist Inc, Danfield Inc, Townsend Leather Company, Inc, Perrone Aerospace, Moore and Giles, Spectra Interior Products and others.

To gain a competitive edge in the market, players are focusing on research and development to launch new variants of genuine leather. Apart from this, players are investing in strategic collaborations, mergers and acquisitions to expand their global footprint. For instance:

  • In April 2018, IZIT® Leather announced to offer a five-year warranty against delamination for its commercial airline seating products, IZIT® XP and XP-A. Rated as the best overall performing synthetic leather by a major U.S. leather testing laboratory, IZIT® Leather offers the commercial air carrier the confidence that seat covers made from IZIT® will withstand the most challenging conditions of wear and abuse while retaining its freshly installed appearance – without delamination.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-14237

U.S. Automotive and Aircraft Interior Genuine Leather Aftermarket by Category

By End-Use:

  • Automotive
    • Passenger Cars
      • Compact
      • Subcompact
      • Mid-Size
      • Sedan
      • Luxury
      • Van
    • LCV
    • HCV
  • Aviation (Aircraft)
    • Narrow Body Aircrafts
    • Wide Body Aircrafts
    • Regional Jets
    • Business Jets
    • Helicopter

By Application:

  • Automotive
    • Upholstery
    • Dashboard
    • Seat belts
    • Airbags
    • Floor & trunk carpets
    • Headliners
    • Others
  • Aviation (Aircrafts)
    • Bottom Covers
    • Backrests
    • Seat Rear Pockets
    • Headrests
    • Armrests

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-14237

By Country:

  • The U.S.